Genomics In Cancer Care Market, Global Outlook and Forecast 2022-2028

March 2022 | 108 pages | ID: GC359869D663EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Genomics In Cancer Care in Global, including the following market information:

Global Genomics In Cancer Care Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Genomics In Cancer Care market was valued at 28420 million in 2021 and is projected to reach US$ 69260 million by 2028, at a CAGR of 13.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Instruments Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Genomics In Cancer Care include Illumina, Thermo Fisher scientific, Agilent, Roche, Cancer Genetics, Beckman Coulter, Bio-Rad, Danaher and Sigma Aldrich, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genomics In Cancer Care companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Genomics In Cancer Care Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Genomics In Cancer Care Market Segment Percentages, by Type, 2021 (%)

• Instruments
• Consumables
• Services

Global Genomics In Cancer Care Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Genomics In Cancer Care Market Segment Percentages, by Application, 2021 (%)

• Diagnostics
• Personalized Medicine
• Drug Discovery
• Development
• Research

Global Genomics In Cancer Care Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Genomics In Cancer Care Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Genomics In Cancer Care revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Genomics In Cancer Care revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Illumina
• Thermo Fisher scientific
• Agilent
• Roche
• Cancer Genetics
• Beckman Coulter
• Bio-Rad
• Danaher
• Sigma Aldrich
• Pacific Biosciences
• Quest Diagnostics
• Luminex
• Oxford Gene Technology
• PerkinElmer
• Qiagen
• GE Healthcare

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Genomics In Cancer Care Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Genomics In Cancer Care Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GENOMICS IN CANCER CARE OVERALL MARKET SIZE

2.1 Global Genomics In Cancer Care Market Size: 2021 VS 2028
2.2 Global Genomics In Cancer Care Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Genomics In Cancer Care Players in Global Market
3.2 Top Global Genomics In Cancer Care Companies Ranked by Revenue
3.3 Global Genomics In Cancer Care Revenue by Companies
3.4 Top 3 and Top 5 Genomics In Cancer Care Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genomics In Cancer Care Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genomics In Cancer Care Players in Global Market
  3.6.1 List of Global Tier 1 Genomics In Cancer Care Companies
  3.6.2 List of Global Tier 2 and Tier 3 Genomics In Cancer Care Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Genomics In Cancer Care Market Size Markets, 2021 & 2028
  4.1.2 Instruments
  4.1.3 Consumables
  4.1.4 Services
4.2 By Type - Global Genomics In Cancer Care Revenue & Forecasts
  4.2.1 By Type - Global Genomics In Cancer Care Revenue, 2017-2022
  4.2.2 By Type - Global Genomics In Cancer Care Revenue, 2023-2028
  4.2.3 By Type - Global Genomics In Cancer Care Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Genomics In Cancer Care Market Size, 2021 & 2028
  5.1.2 Diagnostics
  5.1.3 Personalized Medicine
  5.1.4 Drug Discovery
  5.1.5 Development
  5.1.6 Research
5.2 By Application - Global Genomics In Cancer Care Revenue & Forecasts
  5.2.1 By Application - Global Genomics In Cancer Care Revenue, 2017-2022
  5.2.2 By Application - Global Genomics In Cancer Care Revenue, 2023-2028
  5.2.3 By Application - Global Genomics In Cancer Care Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Genomics In Cancer Care Market Size, 2021 & 2028
6.2 By Region - Global Genomics In Cancer Care Revenue & Forecasts
  6.2.1 By Region - Global Genomics In Cancer Care Revenue, 2017-2022
  6.2.2 By Region - Global Genomics In Cancer Care Revenue, 2023-2028
  6.2.3 By Region - Global Genomics In Cancer Care Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Genomics In Cancer Care Revenue, 2017-2028
  6.3.2 US Genomics In Cancer Care Market Size, 2017-2028
  6.3.3 Canada Genomics In Cancer Care Market Size, 2017-2028
  6.3.4 Mexico Genomics In Cancer Care Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Genomics In Cancer Care Revenue, 2017-2028
  6.4.2 Germany Genomics In Cancer Care Market Size, 2017-2028
  6.4.3 France Genomics In Cancer Care Market Size, 2017-2028
  6.4.4 U.K. Genomics In Cancer Care Market Size, 2017-2028
  6.4.5 Italy Genomics In Cancer Care Market Size, 2017-2028
  6.4.6 Russia Genomics In Cancer Care Market Size, 2017-2028
  6.4.7 Nordic Countries Genomics In Cancer Care Market Size, 2017-2028
  6.4.8 Benelux Genomics In Cancer Care Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Genomics In Cancer Care Revenue, 2017-2028
  6.5.2 China Genomics In Cancer Care Market Size, 2017-2028
  6.5.3 Japan Genomics In Cancer Care Market Size, 2017-2028
  6.5.4 South Korea Genomics In Cancer Care Market Size, 2017-2028
  6.5.5 Southeast Asia Genomics In Cancer Care Market Size, 2017-2028
  6.5.6 India Genomics In Cancer Care Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Genomics In Cancer Care Revenue, 2017-2028
  6.6.2 Brazil Genomics In Cancer Care Market Size, 2017-2028
  6.6.3 Argentina Genomics In Cancer Care Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Genomics In Cancer Care Revenue, 2017-2028
  6.7.2 Turkey Genomics In Cancer Care Market Size, 2017-2028
  6.7.3 Israel Genomics In Cancer Care Market Size, 2017-2028
  6.7.4 Saudi Arabia Genomics In Cancer Care Market Size, 2017-2028
  6.7.5 UAE Genomics In Cancer Care Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Illumina
  7.1.1 Illumina Corporate Summary
  7.1.2 Illumina Business Overview
  7.1.3 Illumina Genomics In Cancer Care Major Product Offerings
  7.1.4 Illumina Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.1.5 Illumina Key News
7.2 Thermo Fisher scientific
  7.2.1 Thermo Fisher scientific Corporate Summary
  7.2.2 Thermo Fisher scientific Business Overview
  7.2.3 Thermo Fisher scientific Genomics In Cancer Care Major Product Offerings
  7.2.4 Thermo Fisher scientific Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.2.5 Thermo Fisher scientific Key News
7.3 Agilent
  7.3.1 Agilent Corporate Summary
  7.3.2 Agilent Business Overview
  7.3.3 Agilent Genomics In Cancer Care Major Product Offerings
  7.3.4 Agilent Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.3.5 Agilent Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Genomics In Cancer Care Major Product Offerings
  7.4.4 Roche Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Cancer Genetics
  7.5.1 Cancer Genetics Corporate Summary
  7.5.2 Cancer Genetics Business Overview
  7.5.3 Cancer Genetics Genomics In Cancer Care Major Product Offerings
  7.5.4 Cancer Genetics Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.5.5 Cancer Genetics Key News
7.6 Beckman Coulter
  7.6.1 Beckman Coulter Corporate Summary
  7.6.2 Beckman Coulter Business Overview
  7.6.3 Beckman Coulter Genomics In Cancer Care Major Product Offerings
  7.6.4 Beckman Coulter Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.6.5 Beckman Coulter Key News
7.7 Bio-Rad
  7.7.1 Bio-Rad Corporate Summary
  7.7.2 Bio-Rad Business Overview
  7.7.3 Bio-Rad Genomics In Cancer Care Major Product Offerings
  7.7.4 Bio-Rad Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.7.5 Bio-Rad Key News
7.8 Danaher
  7.8.1 Danaher Corporate Summary
  7.8.2 Danaher Business Overview
  7.8.3 Danaher Genomics In Cancer Care Major Product Offerings
  7.8.4 Danaher Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.8.5 Danaher Key News
7.9 Sigma Aldrich
  7.9.1 Sigma Aldrich Corporate Summary
  7.9.2 Sigma Aldrich Business Overview
  7.9.3 Sigma Aldrich Genomics In Cancer Care Major Product Offerings
  7.9.4 Sigma Aldrich Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.9.5 Sigma Aldrich Key News
7.10 Pacific Biosciences
  7.10.1 Pacific Biosciences Corporate Summary
  7.10.2 Pacific Biosciences Business Overview
  7.10.3 Pacific Biosciences Genomics In Cancer Care Major Product Offerings
  7.10.4 Pacific Biosciences Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.10.5 Pacific Biosciences Key News
7.11 Quest Diagnostics
  7.11.1 Quest Diagnostics Corporate Summary
  7.11.2 Quest Diagnostics Business Overview
  7.11.3 Quest Diagnostics Genomics In Cancer Care Major Product Offerings
  7.11.4 Quest Diagnostics Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.11.5 Quest Diagnostics Key News
7.12 Luminex
  7.12.1 Luminex Corporate Summary
  7.12.2 Luminex Business Overview
  7.12.3 Luminex Genomics In Cancer Care Major Product Offerings
  7.12.4 Luminex Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.12.5 Luminex Key News
7.13 Oxford Gene Technology
  7.13.1 Oxford Gene Technology Corporate Summary
  7.13.2 Oxford Gene Technology Business Overview
  7.13.3 Oxford Gene Technology Genomics In Cancer Care Major Product Offerings
  7.13.4 Oxford Gene Technology Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.13.5 Oxford Gene Technology Key News
7.14 PerkinElmer
  7.14.1 PerkinElmer Corporate Summary
  7.14.2 PerkinElmer Business Overview
  7.14.3 PerkinElmer Genomics In Cancer Care Major Product Offerings
  7.14.4 PerkinElmer Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.14.5 PerkinElmer Key News
7.15 Qiagen
  7.15.1 Qiagen Corporate Summary
  7.15.2 Qiagen Business Overview
  7.15.3 Qiagen Genomics In Cancer Care Major Product Offerings
  7.15.4 Qiagen Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.15.5 Qiagen Key News
7.16 GE Healthcare
  7.16.1 GE Healthcare Corporate Summary
  7.16.2 GE Healthcare Business Overview
  7.16.3 GE Healthcare Genomics In Cancer Care Major Product Offerings
  7.16.4 GE Healthcare Genomics In Cancer Care Revenue in Global Market (2017-2022)
  7.16.5 GE Healthcare Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Genomics In Cancer Care Market Opportunities & Trends in Global Market
Table 2. Genomics In Cancer Care Market Drivers in Global Market
Table 3. Genomics In Cancer Care Market Restraints in Global Market
Table 4. Key Players of Genomics In Cancer Care in Global Market
Table 5. Top Genomics In Cancer Care Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Genomics In Cancer Care Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Genomics In Cancer Care Revenue Share by Companies, 2017-2022
Table 8. Global Companies Genomics In Cancer Care Product Type
Table 9. List of Global Tier 1 Genomics In Cancer Care Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genomics In Cancer Care Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Genomics In Cancer Care Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Genomics In Cancer Care Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Genomics In Cancer Care Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Genomics In Cancer Care Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Genomics In Cancer Care Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Genomics In Cancer Care Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Genomics In Cancer Care Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Genomics In Cancer Care Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Genomics In Cancer Care Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Genomics In Cancer Care Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Genomics In Cancer Care Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Genomics In Cancer Care Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Genomics In Cancer Care Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Genomics In Cancer Care Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Genomics In Cancer Care Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Genomics In Cancer Care Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Genomics In Cancer Care Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Genomics In Cancer Care Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Genomics In Cancer Care Revenue, (US$, Mn), 2023-2028
Table 30. Illumina Corporate Summary
Table 31. Illumina Genomics In Cancer Care Product Offerings
Table 32. Illumina Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 33. Thermo Fisher scientific Corporate Summary
Table 34. Thermo Fisher scientific Genomics In Cancer Care Product Offerings
Table 35. Thermo Fisher scientific Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 36. Agilent Corporate Summary
Table 37. Agilent Genomics In Cancer Care Product Offerings
Table 38. Agilent Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Genomics In Cancer Care Product Offerings
Table 41. Roche Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 42. Cancer Genetics Corporate Summary
Table 43. Cancer Genetics Genomics In Cancer Care Product Offerings
Table 44. Cancer Genetics Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 45. Beckman Coulter Corporate Summary
Table 46. Beckman Coulter Genomics In Cancer Care Product Offerings
Table 47. Beckman Coulter Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 48. Bio-Rad Corporate Summary
Table 49. Bio-Rad Genomics In Cancer Care Product Offerings
Table 50. Bio-Rad Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 51. Danaher Corporate Summary
Table 52. Danaher Genomics In Cancer Care Product Offerings
Table 53. Danaher Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 54. Sigma Aldrich Corporate Summary
Table 55. Sigma Aldrich Genomics In Cancer Care Product Offerings
Table 56. Sigma Aldrich Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 57. Pacific Biosciences Corporate Summary
Table 58. Pacific Biosciences Genomics In Cancer Care Product Offerings
Table 59. Pacific Biosciences Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 60. Quest Diagnostics Corporate Summary
Table 61. Quest Diagnostics Genomics In Cancer Care Product Offerings
Table 62. Quest Diagnostics Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 63. Luminex Corporate Summary
Table 64. Luminex Genomics In Cancer Care Product Offerings
Table 65. Luminex Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 66. Oxford Gene Technology Corporate Summary
Table 67. Oxford Gene Technology Genomics In Cancer Care Product Offerings
Table 68. Oxford Gene Technology Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 69. PerkinElmer Corporate Summary
Table 70. PerkinElmer Genomics In Cancer Care Product Offerings
Table 71. PerkinElmer Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 72. Qiagen Corporate Summary
Table 73. Qiagen Genomics In Cancer Care Product Offerings
Table 74. Qiagen Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)
Table 75. GE Healthcare Corporate Summary
Table 76. GE Healthcare Genomics In Cancer Care Product Offerings
Table 77. GE Healthcare Genomics In Cancer Care Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Genomics In Cancer Care Segment by Type in 2021
Figure 2. Genomics In Cancer Care Segment by Application in 2021
Figure 3. Global Genomics In Cancer Care Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Genomics In Cancer Care Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Genomics In Cancer Care Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2021
Figure 8. By Type - Global Genomics In Cancer Care Revenue Market Share, 2017-2028
Figure 9. By Application - Global Genomics In Cancer Care Revenue Market Share, 2017-2028
Figure 10. By Region - Global Genomics In Cancer Care Revenue Market Share, 2017-2028
Figure 11. By Country - North America Genomics In Cancer Care Revenue Market Share, 2017-2028
Figure 12. US Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Genomics In Cancer Care Revenue Market Share, 2017-2028
Figure 16. Germany Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 17. France Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Genomics In Cancer Care Revenue Market Share, 2017-2028
Figure 24. China Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 28. India Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Genomics In Cancer Care Revenue Market Share, 2017-2028
Figure 30. Brazil Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Genomics In Cancer Care Revenue Market Share, 2017-2028
Figure 33. Turkey Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Genomics In Cancer Care Revenue, (US$, Mn), 2017-2028
Figure 37. Illumina Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Thermo Fisher scientific Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Agilent Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Cancer Genetics Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Beckman Coulter Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bio-Rad Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Danaher Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Sigma Aldrich Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pacific Biosciences Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Quest Diagnostics Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Luminex Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Oxford Gene Technology Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. PerkinElmer Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Qiagen Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. GE Healthcare Genomics In Cancer Care Revenue Year Over Year Growth (US$, Mn) & (2017-2022)